Cannabis events, top CBD products for moms, and investing in the cannabis industry top Medical Marijuana, Inc.’s headlines this week.
Medical Marijuana, Inc. and our family of companies continue to be leaders in the cannabis industry, as demonstrated by the inclusion of our companies in a number of news stories this past week. Here are our highlights.
Medical Marijuana, Inc. and our CEO Dr. Stuart Titus were included among the ten top cannabis companies and their leadership in an article in Entrepreneur Magazine that investigated the potential effects stemming from the resignation of Jeff Session, the nation’s former Attorney general.
In the article, Dr. Titus was quoted saying, “The unexpected resignation of U.S. Attorney General Jeff Sessions represents another positive event for the cannabis industry. Sessions’ stance on cannabis had been a major impediment toward cannabis reform, and now industry participants hold new hopes for sweeping change at the Federal level. Along with the defeat of Pete Sessions in the U.S. House of Representatives, there is renewed enthusiasm for cannabis-friendly legislation to be passed in the coming year.”
With the exit of Jeff Session and the introduction of Matthew Whitaker as U.S. Attorney General, the cannabis industry is forced to play a waiting game until his approach to legal cannabis is revealed. However, according to the article, “One thing is clear based on these ten cannabis executives’ perspectives. The resignation of Attorney General Jeff Sessions is expected to be a positive change for the marijuana industry.”
You can find the latest cannabis industry news here.
Medical Marijuana, Inc. Listed as Investment Opportunity
A recent article posted on Equities.com looks at the recent cannabis stock boom and the companies worth investing in across the cannabis sector. While recognizing the risk behind investing in products that are controlled at the national level, the article also points out the immense potential for growth in this rapidly expanding industry.
The article reads, “There are some risks. It’s a volatile market, and there will likely soon be too much product in Canada as supply overcompensates for demand. Timing will prove vital, as federal laws could relax, or states could vote to legalize, at least in part, some drugs. The opportunity for investment, however, is still currently viable.”
You can learn more about investing in Medical Marijuana, Inc. here.
Popular parenting site Daily Mom featured CBD oil products from Kannaway as among the 22 best on the market in an article titled, “22 CBD Products That Will Change Your Life”. The article features a wide range of CBD from top manufacturers, including two brands from Kannaway: the company’s Rev!ve CBD tinctures and Essential Oils.
Of Kannaway’s Rev!ve line, the article said, “Give yourself a boost of energy every morning with Rev!ve AM from Kannaway, or help yourself fall asleep with Rev!ve PM. Rev!ve AM contains 10 mg of CBD oil along with their Bîbong Blend of astragalus, ginseng, goji berry, licorice root, and other unique blends to create an energizing morning. Rev!ve PM contains 16.67 mg of CBD oil along with ginseng root, euphoria root, and other unique blends to create a peaceful night’s rest. Both are taken orally.”
“Cannabis oil can be used in a variety of ways, and every day essential oils will help keep everyone in the family feeling like their best selves,” the article continues. “This essential oil trio from Kannaway helps with energy, tranquility, and immunity – all the things a busy family needs during their daily lives. These oils can be diffused in an essential oil diffuser or applied topically if diluted with coconut oil in a roller.”
You can learn more about Kannaway here.
Cannabis Stock Reporters Take Notice of HempMeds® Events
Last week, MMJ Reporter looked at recent activity from the Medical Marijuana, Inc. portfolio of companies, including the participation of HempMeds® in the recent Supplyside West event in Las Vegas. A business-to-business event, Supplyside West allowed HempMeds® to demonstrate its line of bulk CBD products as a potential ingredient in a wide range of finished products. The event expected 16,000 attendees throughout the event.
“We are delighted to exhibit our line of our award-winning CBD products at this year’s conference,” said HempMeds President Todd Morrow in the article. “We are committed to supplying the highest quality CBD to retailers and wholesalers throughout the U.S. and this event will offer invaluable opportunities to network and expand our reach.”
The article continues, “Medical Marijuana Inc (OTCMKTS:MJNA) generated sales of $14.8M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 40.5% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($3.8M against $2.1M).”
You can find more Medical Marijuana, Inc. portfolio news here.